2012, FDA and World Health - Health Care Compliance Brief

SQA Regulatory Surveillance Summary for March and April 2024

SQA

AUGUST 1, 2024

The adoption of these mechanisms is recommended and encouraged by the World Health Organization (WHO) so that the population has faster access to health services and technologies. In addition, the ISPE Guide outlines the authority of State Boards of Pharmacy and their coordination of oversight with the FDA.

FDA

FDA Licensing Compliance World Health

FDA’s Brief To The Fifth Circuit in the AHM Case Is Worth A Read

Drug & Device Law

MAY 11, 2023

A perusal of amicus briefs drew more than a few “they should know what they are talking about here” responses to groups of food and drug law scholars (as opposed to DDL bloggers), former FDA commissioners, former FDA officials, and former DOJ officials, among others. The appellate brief from FDA bears that out well.

FDA

FDA COVID-19 Public Health World Health

Health Care Compliance Brief

SQA Regulatory Surveillance Summary for March and April 2024

FDA’s Brief To The Fifth Circuit in the AHM Case Is Worth A Read

Webinars

Stay Connected